Skip to main content

Investor Portal

Secure, transparent, and high-yield investment opportunities.

High Growth Potential

Targeting sectors with double-digit annual growth rates.

Risk Mitigation

Diversified portfolio across asset classes and geographies.

Impact Driven

Generate financial returns while creating positive social change.

Our Investment Thesis

We believe that the most successful companies of the future will be those that solve the world's biggest challenges.

By directing capital towards education, sustainability, and inclusion, we unlock value that traditional models overlook.

Our portfolio combines the stability of UK real estate with the growth potential of technology ventures, creating a balanced risk-return profile designed to outperform in any market cycle.

Security & Compliance

FCA Compliant Structure

Adhering to strict UK financial regulations.

Asset Backed

Investments secured by tangible real estate assets.

Regular Audits

Quarterly financial audits by independent firms.

Data Privacy

Enterprise-grade encryption for all investor data.

Request Full Access

Please complete the form below to access our detailed investment memorandums.

Access is restricted to qualified investors.

Frequently Asked Questions

What is the minimum investment?

Our minimum investment ticket starts at £100,000 for sophisticated investors.

How are returns distributed?

Returns are distributed quarterly or reinvested based on your preference.

Can international investors join?

Yes, we accept investors from most jurisdictions, subject to KYC/AML checks.

What is the exit strategy?

Investors may exit after the agreed lock-up period, typically 24–36 months, with structured liquidity windows available annually.

Is GInnova regulated?

GInnova operates as a private limited company registered in England and Wales under company number 16619391, and conducts its business activities in compliance with applicable UK laws and regulations.

Due Diligence Documents

Access our key financial and operational documents.